The current stock price of LVGO is 139.77 null. In the past month the price decreased by -0.81%. In the past year, price increased by 520.65%.
Livongo Health Inc. is a consumer digital health company. It offers Enter Livongo platform, which leverages data science and technology, for people with chronic conditions. The Company's Livongo platform offers solutions, such as Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management and Livongo for Behavioral Health by myStrength. Livongo Health Inc. is based in Mountain View, United States.
Livongo Health Inc
150 WEST EVELYN AVENUE SUITE 150
MOUNTAIN VIEW CA 94041
CEO: Zane Burke
Phone: 866-435-5643
Livongo Health Inc. is a consumer digital health company. It offers Enter Livongo platform, which leverages data science and technology, for people with chronic conditions. The Company's Livongo platform offers solutions, such as Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management and Livongo for Behavioral Health by myStrength. Livongo Health Inc. is based in Mountain View, United States.
The current stock price of LVGO is 139.77 null. The price decreased by -3.87% in the last trading session.
LVGO does not pay a dividend.
LVGO has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Livongo Health Inc (LVGO) has a market capitalization of 14.20B null. This makes LVGO a Large Cap stock.
ChartMill assigns a technical rating of 7 / 10 to LVGO. When comparing the yearly performance of all stocks, LVGO is one of the better performing stocks in the market, outperforming 99.23% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to LVGO. LVGO has a great financial health rating, but its profitability evaluates not so good.
Over the last trailing twelve months LVGO reported a non-GAAP Earnings per Share(EPS) of -0.34. The EPS increased by 111.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -13.59% | ||
| ROA | -3.34% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |